Explained herein are pharmaceutical packaging units which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medication, such units which includes a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite minimal permeability to oxygen and comprises et